Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Fruchart

Showing results (41-50 of 538) with videos related to

Pageof 54
Sort By:
Critical Reviews in Clinical Laboratory Sciences|June 1, 1996
HDL heterogeneity and atherosclerosisA Tailleux, J C Fruchart
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|March 1, 1981
[Bioclinical importance of blood ferritin determination]P Duthilleul, J C Fruchart
Biochimie|May 20, 1998
High density lipoproteins and coronary heart disease. Future prospects in gene therapyJ C Fruchart, P Duriez
Biochemical Society Transactions|August 1, 1993
Triglyceride-rich particles, high-density lipoprotein and their pharmacological modulationJ M Bard, J C Fruchart
Clinical Biochemistry|April 1, 1993
HDL particle measurements: impact for diagnosis and therapyJ M Bard, J C Fruchart
Current Medical Research and Opinion|January 1, 1997
Is cholesterol the major lipoprotein risk factor in coronary heart disease?--a Franco-Scottish overviewJ C Fruchart, C J Packard
Current Opinion in Lipidology|August 4, 1999
Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosisJ C Fruchart, P Duriez, B Staels
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|December 1, 1975
[Determination of blood salicylate levels in humans after intravenous and intramuscular administration of lysine acetylsalicylate]H Warembourg, H Delbecque, J C Fruchart
Journal of Cardiovascular Risk|September 12, 2001
PPARS in inflammation, atherosclerosis and thrombosisH Duez, J C Fruchart, B Staels
The Journal of Endocrinology|May 26, 2001
Peroxisome proliferator-activated receptors in inflammation controlP Delerive, J C Fruchart, B Staels
Pageof 54

Showing results (41-50 of 538) with videos related to

Sort By:
Pageof 54
Critical Reviews in Clinical Laboratory Sciences|June 1, 1996
HDL heterogeneity and atherosclerosisA Tailleux, J C Fruchart
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|March 1, 1981
[Bioclinical importance of blood ferritin determination]P Duthilleul, J C Fruchart
Biochimie|May 20, 1998
High density lipoproteins and coronary heart disease. Future prospects in gene therapyJ C Fruchart, P Duriez
Biochemical Society Transactions|August 1, 1993
Triglyceride-rich particles, high-density lipoprotein and their pharmacological modulationJ M Bard, J C Fruchart
Clinical Biochemistry|April 1, 1993
HDL particle measurements: impact for diagnosis and therapyJ M Bard, J C Fruchart
Current Medical Research and Opinion|January 1, 1997
Is cholesterol the major lipoprotein risk factor in coronary heart disease?--a Franco-Scottish overviewJ C Fruchart, C J Packard
Current Opinion in Lipidology|August 4, 1999
Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosisJ C Fruchart, P Duriez, B Staels
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|December 1, 1975
[Determination of blood salicylate levels in humans after intravenous and intramuscular administration of lysine acetylsalicylate]H Warembourg, H Delbecque, J C Fruchart
Journal of Cardiovascular Risk|September 12, 2001
PPARS in inflammation, atherosclerosis and thrombosisH Duez, J C Fruchart, B Staels
The Journal of Endocrinology|May 26, 2001
Peroxisome proliferator-activated receptors in inflammation controlP Delerive, J C Fruchart, B Staels
Pageof 54